HH Parving, P Hovind, K Rossing, S … - Current Opinion in Nephrology and Hypertension, 2001 - journals.lww.com A cumulative incidence of diabetic nephropathy of 25±40% has been documented
after duration of diabetes of at least 25 years in both type 1 and type 2
diabetic patients. Diabetic nephropathy has become the leading cause ... Cited by 80 - Related articles - BL Direct - All 5 versions
BJ Davis, Z Cao, M de Gasparo, H Kawachi, … - Journal of hypertension, 2003 - journals.lww.com Cited Here...: Valsartan treatment reduced systolic blood pressure as assessed
by radiotelemetry (135 ± 3 versus diabetic 153 ± 6 mmHg) as well as retarding
the increase in albumin excretion rate by approximately 50%. Combination ... Cited by 61 - Related articles - BL Direct - All 3 versions
RE Gilbert, H Krum, J Wilkinson-Berka, DJ … - Diabetic Medicine, 2003 - pt.wkhealth.com The relationship between the renin-angiotensin system (RAS) and the progression
of diabetic renal disease has been a major focus of investigation over the past
20 years. More recently, experimental and clinical studies have also ... Cited by 51 - Related articles - BL Direct - All 7 versions
J Karalliedde, G Viberti - Journal of human hypertension, 2006 - nature.com The incidence of end-stage renal disease (ESRD) is rising worldwide, accompanied
by corresponding increases in the risk of morbidity and mortality. Underlying
this trend are increasing rates of hypertension and diabetes mellitus, the ... Cited by 45 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org H Herlitz, K Harris, T Risler, G Boner, J … - Nephrology Dialysis Transplantation, 2001 - ERA-EDTA Methods. We conducted an open long-term randomized prospective multi-centre
study comparing the combination of ramipril (R) and felodipine ER (F) with
either drug alone in non-diabetic renal disease. Included were patients ... Cited by 41 - Related articles - BL Direct - All 4 versions
CE Mogensen, ME Cooper - Diabetic Medicine, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 40 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org ZT Bloomgarden - Diabetes Care, 2005 - Am Diabetes Assoc At a symposium on the development of diabetic nephropathy, Erwin Böttinger (New
York, NY) discussed the molecular pathology of diabetic nephropathy in mice and
men, referring to the growing problems of chronic kidney disease (CKD) due ... Cited by 36 - Related articles - BL Direct - All 11 versions
- ►asnjournals.org G Deferrari, M Ravera, L Deferrari, S Vettoretti … - Journal of the American Society of Nephrology, 2002 - Am Soc Nephrol Hypertension is an extremely common comorbid condition in type 2 diabetes. Its
prevalence is higher than in the general population, thus contributing to
explain the increased risk of both microvascular and macrovascular ... Cited by 31 - Related articles - BL Direct - All 5 versions
G Deferrari, V Cheli, C Robaudo - Diabetes/ Metabolism Reviews, 1997 - interscience.wiley.com Diabetic nephropathy is one of the most frequent causes of end-stage renal
disease (ESRD), and, in recent years, the number of diabetic patients entering
renal replacement therapy has dramatically increased. The magnitude of the ... Cited by 29 - Related articles - BL Direct - All 7 versions
CN Gashti, GL Bakris - Current opinion in nephrology and hypertension, 2004 - journals.lww.com Purpose of review To review goals of antihypertensive treatment in chronic
kidney disease in the context of what role calcium antagonists play toward
reducing progression of kidney disease. Recent findings All recently ... Cited by 27 - Related articles - BL Direct - All 7 versions
